World's Best Scientists 2026 revealed!
Ahcène Boumendjel

Ahcène Boumendjel

D-Index & Metrics

Chemistry

D-Index
45
Citations
6467
World Ranking
16558
National Ranking
723

Ahcène Boumendjel publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Ahcène Boumendjel sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 172 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Ahcène Boumendjel D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ahcène Boumendjel sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 45 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Ahcène Boumendjel is affiliated with Grenoble Alpes University in France and contributes extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans multiple subfields including molecular biology, pharmacology, oncology, materials chemistry, and biochemistry.

The scientist's main topics of work include:

  • Drug Transport and Resistance Mechanisms
  • Phytochemicals and Antioxidant Activities
  • Synthesis of Organic Compounds
  • Computational Drug Discovery Methods
  • HIV/AIDS drug development and treatment
  • Cancer therapeutics and mechanisms
  • Trace Elements in Health

Ahcène Boumendjel has published in several frequent venues, demonstrating a broad engagement in medicinal chemistry and molecular studies. These venues include:

  • European Journal of Medicinal Chemistry (8 publications)
  • Molecules (4 publications)
  • Future Medicinal Chemistry (3 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (3 publications)
  • The Cambridge Structural Database (3 publications)

Recent published papers by Boumendjel and colleagues cover a range of topics related to drug mechanisms, cancer therapeutics, and molecular transport. Examples include:

  • Focus on the high therapeutic potentials of quercetin and its derivatives, 2022, Phytomedicine Plus
  • Substrate-bound and substrate-free outward-facing structures of a multidrug ABC exporter, 2022, Science Advances
  • Molecular analysis of the massive GSH transport mechanism mediated by the human Multidrug Resistant Protein 1/ABCC1, 2020, Scientific Reports
  • Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance, 2020, Molecules
  • Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery, 2022, Pharmaceutics

The scientist frequently collaborates with a consistent group of co-authors, indicating sustained research partnerships. Key co-author names include:

  • Pierre Falson (15 collaborations)
  • Basile Pérès (10 collaborations)
  • Vincent Chaptal (7 collaborations)
  • Kim-Anh Nguyen (6 collaborations)
  • Christian Philouze (6 collaborations)

Best Publications

  • Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters.

    A. Di Pietro;G. Conseil;J.M. Pérez-Victoria;G. Dayan

  • Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.

    Ahcène Boumendjel;Julien Boccard;Pierre-Alain Carrupt;Edwige Nicolle

  • Targeting the Achilles Heel of Multidrug-Resistant Cancer by Exploiting the Fitness Cost of Resistance

    Gergely Szakács;Matthew D. Hall;Michael M. Gottesman;Ahcène Boumendjel

  • Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance

    Ahcène Boumendjel;Attilio Di Pietro;Charles Dumontet;Denis Barron

  • Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.

    Sabrina Okombi;Delphine Rival;Sébastien Bonnet;Anne-Marie Mariotte

  • Aurones: a subclass of flavones with promising biological potential.

    Ahcene Boumendjel

  • Halogenated Chalcones with High-Affinity Binding to P-Glycoprotein: Potential Modulators of Multidrug Resistance

    F. Bois;C. Beney;A. Boumendjel;A.-M. Mariotte

  • Modulation of P-Glycoprotein-Mediated Multidrug Resistance by Flavonoid Derivatives and Analogues

    Mohamed Hadjeri;Magali Barbier;Xavier Ronot;Anne-Marie Mariotte

  • Recent advances in the medicinal chemistry of aurones.

    Haudecoeur R;Boumendjel A

  • Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase

    Sabrina Okombi;Delphine Rival;Sébastien Bonnet;Anne-Marie Mariotte

  • Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

    Romain Haudecoeur;Abdelhakim Ahmed-Belkacem;Wei Yi;Antoine Fortuné

  • Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship.

    E. Nicolle;F. Souard;P. Faure;A. Boumendjel

  • Chalcones Derivatives Acting as Cell Cycle Blockers: Potential Anti Cancer Drugs?

    Ahcene Boumendjel;Xavier Ronot;Jean Boutonnat

  • Flavonoids as RTK inhibitors and potential anticancer agents

    Florence Teillet;Ahcene Boumendjel;Jean Boutonnat;Xavier Ronot

  • Flavonoide esters and their use notably in cosmetics

    Eric Perrier;Anne-Marie Mariotte;Ahcene Boumendjel;Delphine Bresson-Rival

  • Acridone derivatives: Design, synthesis, and inhibition of breast cancer resistance protein ABCG2

    Ahcene Boumendjel;Sira Macalou;Abdelhakim Ahmed-Belkacem;Madeleine Blanc

  • Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones.

    Mohamed Hadjeri;Eva-Laure Peiller;Chantal Beney;Nabajyoti Deka

  • Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance.

    Frédéric Bois;Ahcène Boumendjel;Anne-Marie Mariotte;Gwenaëlle Conseil

  • Occurrences, biosynthesis and properties of aurones as high-end evolutionary products.

    Benjamin Boucherle;Marine Peuchmaur;Ahcène Boumendjel;Romain Haudecoeur

  • A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models

    Ahcene Boumendjel;Anne McLeer-Florin;Pierre Champelovier;Diane Allegro

  • Investigation of Chalcones as Selective Inhibitors of the Breast Cancer Resistance Protein: Critical Role of Methoxylation in both Inhibition Potency and Cytotoxicity

    Glaucio Valdameri;Glaucio Valdameri;Charlotte Gauthier;Raphaël Terreux;Rémy Kachadourian

  • Botany, traditional uses, phytochemistry and pharmacology of Waltheria indica L. (syn. Waltheria americana): a review.

    F. Zongo;C. Ribuot;A. Boumendjel;I. Guissou

Frequent Co-Authors

Attilio Di Pietro
Attilio Di Pietro University of Lyon System
Michel De Waard
Michel De Waard University of Nantes
Pierre-Alain Carrupt
Pierre-Alain Carrupt École Polytechnique Fédérale de Lausanne
Jean-Luc Wolfender
Jean-Luc Wolfender University of Geneva
Brian J. Day
Brian J. Day National Jewish Health
Luigi Bubacco
Luigi Bubacco University of Padua
Rajendra Prasad
Rajendra Prasad Amity University
Denis Barron
Denis Barron Nestlé (Switzerland)
Antoine Depaulis
Antoine Depaulis Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying chemistry in the USA opens doors to a broad range of career paths, often supported by specialized online degrees. For those interested in healthcare and sales, becoming a pharmaceutical sales representative is a viable option. To understand the financial prospects, explore how much do drug reps make, which highlights earning potential and career growth.

Another common pathway for chemistry graduates is pursuing a career as a pharmacist. The journey typically requires advanced education and licensure; detailed guidance on how to become a pharmacist can clarify this process for aspiring students.

Forensic science is an exciting field where chemistry skills are invaluable. Many students consider an online bachelor's degree in forensic science, which offers flexibility and comprehensive training relevant to this rapidly evolving sector.

Lastly, roles such as autopsy technicians combine chemistry and biology expertise with hands-on experience. Understanding the job outlook and compensation is easier by reviewing how much do autopsy techs make, providing realistic expectations for this niche career.

By exploring these related online degrees and career pathways, chemistry students can better plan their educational journey and professional futures.

Best Scientists Citing Ahcène Boumendjel

Trending Scientists

Recently Published Articles